Wales invests £1.21m in new laboratory for newborn screening

The Welsh Government has announced a £1.21 million investment to establish a new biochemistry laboratory at University Hospital Wales (UHW) in Cardiff. This facility is designed to expand the All-Wales Newborn Bloodspot Screening Service, which currently tests approximately 28,000 babies annually for nine rare diseases, including cystic fibrosis and congenital hypothyroidism.

An additional £529,000 has been allocated to include testing for Hereditary Tyrosinemia Type 1, following recommendations from the UK National Screening Committee. The new infrastructure will also allow Wales to participate in evaluations for potential future screening of Spinal Muscular Atrophy (SMA) and Severe Combined Immune Deficiency (SCID).

Early detection through these bloodspot tests, typically performed by midwives on a baby’s heel between days four and six of life, allows for early medical intervention. Such treatment can improve health outcomes and prevent severe disability or death.